ArticleJournal of molecular medicine (Berlin, Germany)2024

A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology.

Kate L Weeks et al.PubMed ↗Publisher ↗

No numbers read from the abstract.